GlassScriptPhysician profile
Stephen M Durkee
NPI 1437113826
$5,871.68
in general payments reported to CMS, 2019-2025
48 companies · $598 in 2025
The $598 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $690 · 2021: $1,668 · 2022: $1,093 · 2023: $637 · 2024: $606 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,840.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,615.42 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Astellas Pharma US INC | $693.52 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $452.50 | 2019-2025 | |
| Allergan, INC. | $231.30 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $214.43 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.96 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $157.29 | 2023-2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $148.78 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $147.99 | 2019-2022 | |
| Hologic Sales and Service, LLC | $146.59 | 2019-2024 | Aptima |
| Novo Nordisk INC | $144.48 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $141.15 | 2022 | |
| Amgen INC. | $120.41 | 2020-2025 | Evenity, Prolia, Prolia |
| Avion Pharmaceuticals | $102.14 | 2019-2022 | |
| Evofem Biosciences, INC. | $95.07 | 2021-2023 | Phexxi |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Durkee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.